Copyright
©The Author(s) 2015.
World J Gastroenterol. Jan 28, 2015; 21(4): 1173-1181
Published online Jan 28, 2015. doi: 10.3748/wjg.v21.i4.1173
Published online Jan 28, 2015. doi: 10.3748/wjg.v21.i4.1173
Table 2 Baseline characteristics of hypertensive patients n (%)
| Endoscopic resection (n = 53) | Subtotal gastrectomy (n = 244) | Total gastrectomy (n = 54) | P | |
| Male | 36 (67.9) | 153 (62.7) | 41 (75.9) | 0.17 |
| Age at treatment (yr, mean ± SE) | 65.2 ± 8.1 | 65.8 ± 8.5 | 66.3 ± 9.3 | 0.79 |
| Comorbid DM | 5 (9.4) | 46 (18.9) | 13 (24.1) | 0.13 |
| Cardiovascular medication | ||||
| Lipid lowering agent | 8 (15.1) | 52 (21.3) | 13 (24.1) | 0.49 |
| Antithrombotic agent | 22 (41.5) | 93 (38.1) | 22 (40.7) | 0.87 |
| Other | 1 (1.9) | 5 (2.0) | 2 (3.7) | 0.85 |
| Antihypertensive agent | ||||
| Calcium channel blocker (C) | 41 (77.4) | 166 (68.0) | 33 (61.1) | 0.19 |
| Diuretics (D) | 19 (35.8) | 92 (37.7) | 21 (38.9) | 0.95 |
| Beta-blocker (B) | 19 (35.8) | 76 (31.1) | 17 (31.5) | 0.80 |
| ACEi or ARB (A) | 15 (28.3) | 82 (33.6) | 18 (33.3) | 0.75 |
| Combination (A, D) | 9 (17.0) | 41 (16.8) | 5 (9.3) | 0.37 |
| Combination (B, D) | 0 (0.0) | 9 (3.7) | 1 (1.9) | 0.54 |
| Combination (A, C) | 0 (0.0) | 6 (2.5) | 3 (5.6) | 0.19 |
| Antihypertensive medications (n) | ||||
| 1 | 18 (33.3) | 73 (29.9) | 16 (30.2) | 0.70 |
| 2 | 25 (46.3) | 97 (39.8) | 22 (41.5) | |
| ≥ 3 | 11 (20.4) | 74 (30.3) | 15 (28.3) | |
- Citation: Lee EK, Kim SY, Lee YJ, Kwak MH, Kim HJ, Choi IJ, Cho SJ, Kim YW, Lee JY, Kim CG, Yoon HM, Eom BW, Kong SY, Yoo MK, Park JH, Ryu KW. Improvement of diabetes and hypertension after gastrectomy: A nationwide cohort study. World J Gastroenterol 2015; 21(4): 1173-1181
- URL: https://www.wjgnet.com/1007-9327/full/v21/i4/1173.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i4.1173